Insight Medbotics is a company dedicated to the development of MRI-guided robotics, aiming to integrate the unique insights offered by MRI technology with the minimally invasive capabilities and precision of robotics.

The company has successfully introduced an MRI-compatible robot named IGAR, which has undergone clinical demonstrations in breast cancer patients. IGAR serves multiple purposes, including biopsy procedures, targeted therapy administration, and device placement within the medical field.

Insight Medbotics is driven by a vision to extend the application of its advanced MRI-guided robotic technology to medical procedures where accuracy and precision are of paramount importance, catering to the needs and expectations of patients, medical practitioners, and healthcare institutions.